Eduardo Urias : Citation Profile


Are you Eduardo Urias?

United Nations University-Maastricht Economic Research Institute of Innovation and Technology (UNU-MERIT) (87% share)
Maastricht University (13% share)

2

H index

0

i10 index

6

Citations

RESEARCH PRODUCTION:

4

Articles

RESEARCH ACTIVITY:

   5 years (2015 - 2020). See details.
   Cites by year: 1
   Journals where Eduardo Urias has often published
   Relations with other researchers
   Recent citing documents: 2.    Total self citations: 2 (25 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pur38
   Updated: 2022-11-19    RAS profile: 2021-06-13    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Eduardo Urias.

Is cited by:

Grepperud, Sverre (1)

Cites to:

Lee, Keun (6)

Ramani, Shyama (4)

Aghion, Philippe (2)

guennif, samira (2)

Suzigan, Wilson (2)

mu, qing (2)

Vickers, John (2)

filippetti, andrea (2)

Howitt, Peter (2)

Dosi, Giovanni (1)

Pernia, Ernesto (1)

Main data


Where Eduardo Urias has published?


Recent works citing Eduardo Urias (2022 and 2021)


YearTitle of citing document
2021Windows of Opportunity in the CoPS’s Catch-Up Process: A Case Study of China’s High-Speed Train Industry. (2021). Zhang, Junfang ; Xiong, Jie ; Huang, Han. In: Sustainability. RePEc:gam:jsusta:v:13:y:2021:i:4:p:2144-:d:500840.

Full description at Econpapers || Download paper

2022TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines. (2022). Stevens, Hilde ; Mermelstein, Shiri. In: ULB Institutional Repository. RePEc:ulb:ulbeco:2013/337220.

Full description at Econpapers || Download paper

Works by Eduardo Urias:


YearTitleTypeCited
2018When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil In: Research Policy.
[Full Text][Citation analysis]
article2
2015Access to critical medicines: When are compulsory licenses effective in price negotiations? In: Social Science & Medicine.
[Full Text][Citation analysis]
article3
2020Access to medicines after TRIPS: Is compulsory licensing an effective mechanism to lower drug prices? A review of the existing evidence In: Journal of International Business Policy.
[Full Text][Citation analysis]
article1
2019The potential synergies between industrial and health policies for access to medicines: insights from the Brazilian policy of universal access to HIV/AIDS treatment In: Innovation and Development.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 1st 2022. Contact: CitEc Team